GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Quratis Inc (XKRX:348080) » Definitions » Cash Flow from Others

Quratis (XKRX:348080) Cash Flow from Others : ₩4,133.1 Mil (TTM As of Sep. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Quratis Cash Flow from Others?

Quratis's cash flow from others for the three months ended in Sep. 2024 was ₩461.9 Mil. Its cash flow from others for the trailing twelve months (TTM) ended in Sep. 2024 was ₩4,133.1 Mil.


Quratis Cash Flow from Others Historical Data

The historical data trend for Quratis's Cash Flow from Others can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Quratis Cash Flow from Others Chart

Quratis Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Flow from Others
Get a 7-Day Free Trial 70,725.35 5,390.27 3,691.05 15,107.99 -690.67

Quratis Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Cash Flow from Others Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 501.20 -2,533.32 330.92 5,873.59 461.92

Quratis Cash Flow from Others Calculation

Cash Flow from Others for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩4,133.1 Mil.

Quratis Cash Flow from Others Related Terms

Thank you for viewing the detailed overview of Quratis's Cash Flow from Others provided by GuruFocus.com. Please click on the following links to see related term pages.


Quratis Business Description

Traded in Other Exchanges
N/A
Address
306, 13, Teheran-ro 64-gil, Gangnam-gu, Seoul, KOR
Quratis Inc operates as a developer of vaccines and therapies designed to treat tuberculosis. The company develops youth and adults tuberculosis vaccines, messenger ribonucleic acids, and other related immune-related vaccines.

Quratis Headlines

No Headlines